Skip to main content
Top
Published in: Esophagus 2/2016

01-04-2016 | Case Report

A case of squamous cell carcinoma initially diagnosed as cN4 with diffuse lymph node swelling which disappeared after the eradication of Helicobacter pylori

Authors: Hiroshi Kawahira, Shinichi Okazumi, Masaya Uesato, Naoyuki Hanari, Yasunori Akutsu, Nobuyuki Hiruta, Hisahiro Matsubara, Ryouji Katoh

Published in: Esophagus | Issue 2/2016

Login to get access

Abstract

A male patient in his early seventies complained of swallowing difficulty and back pain. Esophagogastroscopy was performed and the patient was diagnosed as squamous cell carcinoma in the middle and lower part of the esophagus with a longitudinal submucosal elevation of 15 cm and S2 stage of gastric ulcer infected by Helicobacter pylori. Multiple lymph node swelling was detected not only in the mediastinum but also in the neck and the para-aortic area by CT scanning. The clinical stage was T3 N4 M0 Stage IVa. Systemic chemotherapy was applied first and the curative effectiveness was SD based on the RECIST criteria. PET revealed accumulation of FDG in the esophageal and stomach wall. These lesions were suspected to be HP-infected esophageal cancer, and Helicobacter pylori elimination was performed. After HP eradication, the tumor of the esophagus, submucosal elevation of esophagus, and gastric ulcer was markedly shrunk. Multiple lymph node swelling was definitely shrunk based on CT. Overall the early esophageal cancer remained. Endoscopic submucosal dissection (ESD) was performed. The pathological diagnosis was Type 0-IIc, pT1b(SM2), ly1, v2, pHM0, pVM0. After ESD, he indicated febrile neutropenia, was diagnosed as myelodysplastic syndrome (MDS) during the follow-up period and chose best supportive care (BSC).
Literature
1.
go back to reference Akutsu Y, Uesato M, Shuto K, et al. The overall prevalence of metastasis in T1 esophageal squamous cell carcinoma: a retrospective analysis of 295 patients. Ann Surg. 2013;257(6):1032–8.CrossRefPubMed Akutsu Y, Uesato M, Shuto K, et al. The overall prevalence of metastasis in T1 esophageal squamous cell carcinoma: a retrospective analysis of 295 patients. Ann Surg. 2013;257(6):1032–8.CrossRefPubMed
2.
go back to reference Islami F, Kamangar F. Helicobacter pylori and esophageal cancer risk: a meta-analysis. Cancer Prev Res (Phila). 2008;1:329–38.CrossRef Islami F, Kamangar F. Helicobacter pylori and esophageal cancer risk: a meta-analysis. Cancer Prev Res (Phila). 2008;1:329–38.CrossRef
4.
go back to reference Raghunath A, Hungin AP, Wooff D, et al. Prevalence of Helicobacter pylori in patients with gastro-oesophageal reflux disease: systematic review. BMJ. 2003;326:737.CrossRefPubMedPubMedCentral Raghunath A, Hungin AP, Wooff D, et al. Prevalence of Helicobacter pylori in patients with gastro-oesophageal reflux disease: systematic review. BMJ. 2003;326:737.CrossRefPubMedPubMedCentral
5.
go back to reference Souza RC, Lima JH. Helicobacter pylori and gastroesophageal reflux disease: a review of this intriguing relationship. Dis Esophagus. 2009;22:256–63.CrossRefPubMed Souza RC, Lima JH. Helicobacter pylori and gastroesophageal reflux disease: a review of this intriguing relationship. Dis Esophagus. 2009;22:256–63.CrossRefPubMed
7.
go back to reference Abe Y, Ohara S, Koike T, et al. The prevalence of Helicobacter pylori infection and the status of gastric acid secretion in patients with Barrett’s esophagus in Japan. Am J Gastroenterol. 2004;99:1213–21.CrossRefPubMed Abe Y, Ohara S, Koike T, et al. The prevalence of Helicobacter pylori infection and the status of gastric acid secretion in patients with Barrett’s esophagus in Japan. Am J Gastroenterol. 2004;99:1213–21.CrossRefPubMed
8.
go back to reference Fischbach LA, Graham DY, Kramer JR, et al. Association between Helicobacter pylori and Barrett’s esophagus: a case-control study. Am J Gastroenterol. 2014;109:357–68.CrossRefPubMedPubMedCentral Fischbach LA, Graham DY, Kramer JR, et al. Association between Helicobacter pylori and Barrett’s esophagus: a case-control study. Am J Gastroenterol. 2014;109:357–68.CrossRefPubMedPubMedCentral
9.
go back to reference Fujita H. Japanese Classification of esophageal Cancer, tenth edition: part I. Tokyo: Kanehara & CO. Ltd; 2009. Fujita H. Japanese Classification of esophageal Cancer, tenth edition: part I. Tokyo: Kanehara & CO. Ltd; 2009.
10.
go back to reference Kuwano H, Nishimura Y, Ohtsu A, et al. Guidelines for diagnosis and treatment of carcinoma of the esophagus April 2007 edition: part I edited by the Japan Esophageal Society. Esophagus. 2008;5:61–73.CrossRef Kuwano H, Nishimura Y, Ohtsu A, et al. Guidelines for diagnosis and treatment of carcinoma of the esophagus April 2007 edition: part I edited by the Japan Esophageal Society. Esophagus. 2008;5:61–73.CrossRef
11.
go back to reference Marshall BJ, Warren JR. Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet. 1984;1:1311–5.CrossRefPubMed Marshall BJ, Warren JR. Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet. 1984;1:1311–5.CrossRefPubMed
12.
go back to reference Contreras M, Salazar V, Garcia-Amado MA, et al. High frequency of Helicobacter pylori in the esophageal mucosa of dyspeptic patients and its possible association with histopathological alterations. Int J Infect Dis. 2012;16:e364–70.CrossRefPubMed Contreras M, Salazar V, Garcia-Amado MA, et al. High frequency of Helicobacter pylori in the esophageal mucosa of dyspeptic patients and its possible association with histopathological alterations. Int J Infect Dis. 2012;16:e364–70.CrossRefPubMed
13.
go back to reference Ying GX, Wen Sheng LI, Xia ZL, et al. CagA+ H. pylori filtrate induces cytokine IL-8 secretion by esophageal squamous carcinoma EC 109 cells via a p38 pathway. Indian J Pathol Microbiol. 2014;57:13–8.CrossRefPubMed Ying GX, Wen Sheng LI, Xia ZL, et al. CagA+ H. pylori filtrate induces cytokine IL-8 secretion by esophageal squamous carcinoma EC 109 cells via a p38 pathway. Indian J Pathol Microbiol. 2014;57:13–8.CrossRefPubMed
14.
go back to reference Xue L, Xing L, Wang J, et al. Serum pepsinogens and Helicobacter pylori are not associated with esophageal squamous cell carcinoma in a high-risk area in China. Tumori. 2013;99:134–8.PubMed Xue L, Xing L, Wang J, et al. Serum pepsinogens and Helicobacter pylori are not associated with esophageal squamous cell carcinoma in a high-risk area in China. Tumori. 2013;99:134–8.PubMed
15.
go back to reference Jung JG, Kang HW, Hahn SJ, et al. Primary mucosa-associated lymphoid tissue lymphoma of the esophagus, manifesting as a submucosal tumor. Korean J Gastroenterol. 2013;62:117–21.CrossRefPubMed Jung JG, Kang HW, Hahn SJ, et al. Primary mucosa-associated lymphoid tissue lymphoma of the esophagus, manifesting as a submucosal tumor. Korean J Gastroenterol. 2013;62:117–21.CrossRefPubMed
Metadata
Title
A case of squamous cell carcinoma initially diagnosed as cN4 with diffuse lymph node swelling which disappeared after the eradication of Helicobacter pylori
Authors
Hiroshi Kawahira
Shinichi Okazumi
Masaya Uesato
Naoyuki Hanari
Yasunori Akutsu
Nobuyuki Hiruta
Hisahiro Matsubara
Ryouji Katoh
Publication date
01-04-2016
Publisher
Springer Japan
Published in
Esophagus / Issue 2/2016
Print ISSN: 1612-9059
Electronic ISSN: 1612-9067
DOI
https://doi.org/10.1007/s10388-015-0494-4

Other articles of this Issue 2/2016

Esophagus 2/2016 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine